Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on AusCann.
RELATED STOCKHEAD STORIES
Health & Biotech
Althea hits its 300th customer while AusCann goes shopping
Health & Biotech
Weed week: pot deals are flying just not in Australia – yet
Escrow Watch
Escrow Watch: Heat wave? 1.5bn escrowed ASX shares are going for a dip
Health & Biotech
AusCann plants JV pot crop in Chile, still doesn’t have a CEO
Health & Biotech
Weed Week: US okays hemp but the Kiwis are eyeing off full legalisation
Health & Biotech
Weed week: wtf happened with MMJ?
Health & Biotech
AusCann to start making pot pain pills, Althea gets export licence
Health & Biotech
Aussie pot stock Cann Group wants to build the first big glass-roof cannabis factory
Health & Biotech
Aussie pot stocks are medical cannabis ‘first-movers’ – but the competition is tough
Health & Biotech
Canada legalises pot this week – here are the ASX stocks that could benefit
Health & Biotech
These seven ASX-listed pot stocks are hoping for a US high
Health & Biotech
Who’s got those all-important golden cannabis licences and who hasn’t
Health & Biotech
The world’s biggest marijuana stock soars to an all-time high
Health & Biotech
Corona maker sinks $4bn into Aussie pot stock AusCann’s biggest shareholder
Health & Biotech
These six Aussie pot stocks raised 70pc of cannabis capital in 2018
Health & Biotech
Pot stock Cann Group ties up with drug-maker IDT; seeks last cannabis licence
Director Trades